1-1 of 1
Ahmad M Adel, MSc
Close
Sort by
Journal Articles

Dasatinib and Nilotinib As Upfront Therapy for Chronic-Phase Chronic Myeloid Leukemia (CML-CP) in Qatar: A Cost Effectiveness Analysis (CEA)

Ahmad M Adel, MSc, Dina Abushanab, MSc, Anas Hamad, PhD, Mohammad Abdul-Jaber Abdulla, MD, Mohamed A Yassin, MBBS, MSc
Journal: Blood
Blood (2019) 134 (Supplement_1): 5850.
https://doi.org/10.1182/blood-2019-121833
Published: 2019